Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China · Delayed Price · Currency is CNY 6.77
-0.21 (-3.01%)
Apr 3, 2026, 3:00 PM CST
SHA:600223 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 237.48 | 243.53 | 303.39 | 45.46 | 361.9 |
Depreciation & Amortization | 107.92 | 99.51 | 147.76 | 121.6 | 94.03 |
Other Amortization | 13.99 | 14.9 | 10.01 | 8.01 | 7.91 |
Loss (Gain) From Sale of Assets | 0.06 | -0.96 | 0.77 | -0.77 | 0.15 |
Asset Writedown & Restructuring Costs | 10.04 | 0.7 | 2.19 | 4.74 | 4.04 |
Loss (Gain) From Sale of Investments | -55.39 | -63.98 | -214.34 | -116.21 | -201.34 |
Provision & Write-off of Bad Debts | - | 28.92 | 38.31 | 66.86 | 101.05 |
Other Operating Activities | 12.64 | 78.74 | 162.9 | 684.2 | 335.79 |
Change in Accounts Receivable | -87.79 | 175.89 | 1,861 | 523.12 | 2,032 |
Change in Inventory | 119.35 | -33.91 | -598.86 | 1,899 | 344.74 |
Change in Accounts Payable | -80.34 | -308.12 | -1,228 | -2,238 | 3,760 |
Change in Other Net Operating Assets | - | - | - | - | 5.59 |
Operating Cash Flow | 276.22 | 228.65 | 474.15 | 998.1 | 6,848 |
Operating Cash Flow Growth | 20.80% | -51.78% | -52.49% | -85.42% | 53.96% |
Capital Expenditures | -110.42 | -157.22 | -211.37 | -166.11 | -281.53 |
Sale of Property, Plant & Equipment | 0.08 | 0.33 | 3.89 | 5.7 | 0.61 |
Divestitures | - | 2,982 | 2,641 | - | 33.05 |
Investment in Securities | 0.06 | 11.68 | 177.52 | 30.83 | -268.32 |
Other Investing Activities | 50.89 | 155.85 | 62.69 | 130.81 | 64.38 |
Investing Cash Flow | -59.38 | 2,993 | 2,673 | 1.24 | -451.81 |
Long-Term Debt Issued | 296.32 | 348 | 2,701 | 12,621 | 9,931 |
Total Debt Issued | 296.32 | 348 | 2,701 | 12,621 | 9,931 |
Long-Term Debt Repaid | -438.5 | -2,235 | -5,281 | -13,161 | -15,351 |
Total Debt Repaid | -438.5 | -2,235 | -5,281 | -13,161 | -15,351 |
Net Debt Issued (Repaid) | -142.18 | -1,887 | -2,580 | -540.61 | -5,420 |
Issuance of Common Stock | - | - | - | 22.47 | 17.05 |
Common Dividends Paid | -65.19 | -183.57 | -487.96 | -1,175 | -2,015 |
Other Financing Activities | -39.79 | -35.02 | -29.69 | 75.44 | 629.44 |
Financing Cash Flow | -247.16 | -2,106 | -3,097 | -1,618 | -6,789 |
Foreign Exchange Rate Adjustments | -0.01 | -0.23 | -1.01 | 9.82 | -0.41 |
Net Cash Flow | -30.33 | 1,116 | 48.93 | -608.61 | -393.24 |
Free Cash Flow | 165.8 | 71.44 | 262.79 | 831.98 | 6,567 |
Free Cash Flow Growth | 132.10% | -72.82% | -68.41% | -87.33% | 53.04% |
Free Cash Flow Margin | 4.54% | 1.79% | 5.74% | 6.42% | 53.12% |
Free Cash Flow Per Share | 0.16 | 0.07 | 0.26 | 0.73 | 6.35 |
Cash Income Tax Paid | 277.93 | 290.52 | 553.18 | 1,099 | 1,786 |
Levered Free Cash Flow | - | 3,107 | 2,879 | 1,837 | 2,779 |
Unlevered Free Cash Flow | - | 3,121 | 2,939 | 2,088 | 2,849 |
Change in Working Capital | -50.53 | -172.71 | 23.18 | 184.2 | 6,145 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.